Influence of aprotinin on the thrombomodulin/protein C system in pediatric cardiac operations.

[1]  T. Sundt,et al.  Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. , 1993, The Annals of thoracic surgery.

[2]  G. Hempelmann,et al.  Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss. , 1993, The Journal of thoracic and cardiovascular surgery.

[3]  K. Mann,et al.  Surface-dependent hemostasis. , 1992, Seminars in hematology.

[4]  K. K. Wu.  Endothelial cells in hemostasis, thrombosis, and inflammation. , 1992, Hospital practice.

[5]  B. Furie,et al.  Molecular and cellular biology of blood coagulation. , 1992, The New England journal of medicine.

[6]  I. Maruyama.  Thrombomodulin, an endothelial anticoagulant; its structure, function and expression. , 1992, Japanese circulation journal.

[7]  D. Royston.  High-dose aprotinin therapy: a review of the first five years' experience. , 1992, Journal of cardiothoracic and vascular anesthesia.

[8]  W. Williams,et al.  Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease. , 1992, The Journal of thoracic and cardiovascular surgery.

[9]  C. Whitten,et al.  What is the mechanism of action of aprotinin? , 1991, Anesthesiology.

[10]  P. Fondu,et al.  Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass , 1991, The Lancet.

[11]  S. Nicolson,et al.  Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children , 1991 .

[12]  H. Gerlach,et al.  Endothelium and Regulation of Coagulation , 1991, Diabetes Care.

[13]  M. Bérard,et al.  Plasma thrombomodulin as a marker of endothelium damage. , 1991, Nouvelle revue francaise d'hematologie.

[14]  R. Hetzer,et al.  Blood Use in Cardiac Surgery , 1991, Steinkopff.

[15]  T. Hayashi,et al.  One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[16]  M. Jochum,et al.  Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. , 1990, Anesthesiology.

[17]  S. Kimura,et al.  Plasma thrombomodulin in health and diseases. , 1990, Blood.

[18]  L. Harker,et al.  Bleeding complications associated with cardiopulmonary bypass. , 1990, Blood.

[19]  H. Böhrer,et al.  Adverse haemodynamic effects of high‐dose aprotinin in a paediatric cardiac surgical patient , 1990, Anaesthesia.

[20]  W. van Oeveren,et al.  Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[21]  I. Yada,et al.  The role of the protein C-thrombomodulin system in physiologic anticoagulation during cardiopulmonary bypass. , 1989, ASAIO transactions.

[22]  D. Cosgrove,et al.  Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.

[23]  P. Knöbl,et al.  The protein C system in patients undergoing cardiopulmonary bypass. , 1987, The Journal of thoracic and cardiovascular surgery.

[24]  P. Powers,et al.  Development of the human coagulation system in the full-term infant. , 1987, Blood.

[25]  Thompson Ea,et al.  The role of thrombomodulin in the regulation of hemostatic interactions. , 1987 .

[26]  R. Bick.  Hemostasis Defects Associated with Cardiac Surgery, Prosthetic Devices, and Other Extracorporeal Circuits , 1985, Seminars in thrombosis and hemostasis.

[27]  W. Murray,et al.  Anaphylactic reaction to aprotinin despite negative ocular sensitivity tests. , 1984, British medical journal.

[28]  R. Colman,et al.  Platelets and extracorporeal circulation. , 1982, Biomaterials.